Literature DB >> 8165052

Increased expression of human 63-kD heat shock protein gene in Kawasaki disease determined by quantitative reverse transcription-polymerase chain reaction.

S Takeshita1, H Kawase, M Yamamoto, T Fujisawa, I Sekine, S Yoshioka.   

Abstract

To investigate the possible role of heat shock protein (HSP) in the pathogenesis of Kawasaki disease (KD), we determined the expression of 63-kD HSP (P1 protein) gene in the leukocytes from the peripheral blood of 20 patients with KD, 20 patients with various other febrile diseases, and 10 healthy children using the quantitative reverse transcription-polymerase chain reaction technique. Although a low but constitutive expression of HSP was observed in the control patients and healthy children, the expression of HSP63 mRNA was significantly higher during the acute phase of KD. Because mycobacterial HSP65, a cognate of human HSP63, is a common immunogen in bacterial species, and because the major immunopathologic feature of KD is reportedly an abnormally activated immune system, it suggests that an increased level of HSP63 gene transcription may be associated with the pathogenesis of KD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8165052     DOI: 10.1203/00006450-199402000-00010

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Increased levels of circulating soluble CD14 in Kawasaki disease.

Authors:  S Takeshita; K Nakatani; H Tsujimoto; Y Kawamura; H Kawase; I Sekine
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  HSP60, HSP70 in the pathogenesis of Kawasaki disease: implication and action.

Authors:  W Lu; P Cheng; S Chen
Journal:  J Tongji Med Univ       Date:  1998

3.  Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease.

Authors:  S Takeshita; T Tokutomi; H Kawase; K Nakatani; H Tsujimoto; Y Kawamura; I Sekine
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

4.  Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease.

Authors:  Seigo Okada; Hiroki Yasudo; Yuji Ohnishi; Chie Matsuguma; Reiji Fukano; Takahiro Motonaga; Takako Waniishi; Shunji Hasegawa
Journal:  Inflammation       Date:  2022-10-08       Impact factor: 4.657

5.  Erythema at BCG Inoculation Site in Kawasaki Disease Patients.

Authors:  Mohammad Sadegh Rezai; Soheila Shahmohammadi
Journal:  Mater Sociomed       Date:  2014-08-26

Review 6.  Kawasaki disease: what is the epidemiology telling us about the etiology?

Authors:  David Burgner; Anthony Harnden
Journal:  Int J Infect Dis       Date:  2005-07       Impact factor: 3.623

7.  Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease.

Authors:  Satoru Nagata; Yuichiro Yamashiro; Yoshikazu Ohtsuka; Toshiaki Shimizu; Yumiko Sakurai; Shigeki Misawa; Teruyo Ito
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.